An experimental drug pairing slowed the spread of advanced prostate cancer on scans in men whose tumors carry BRCA mutations.
In a large, international trial across 32 countries, adding niraparib to abiraterone and prednisone cut the risk of…
An experimental drug pairing slowed the spread of advanced prostate cancer on scans in men whose tumors carry BRCA mutations.
In a large, international trial across 32 countries, adding niraparib to abiraterone and prednisone cut the risk of…